OpenEvidence, the ChatGPT for docs, raises $200M at $6B valuation
OpenEvidence, a instrument that docs and nurses have likened to ChatGPT for drugs, plans to announce a $200 million elevate at a $6 billion valuation, The New York Occasions studies. The recent funds come three months after the startup raised a $210 million spherical at a $3.5 billion valuation, a testomony to the extraordinary investor curiosity in industry-specific AI purposes. Skilled on…













